ZA7-71792-11656

2 vaccinations 11 coded responses 22 check-ins 11 free-text entries 7 call cases

Sex: —
Age at first dose: 46-50
ZIP prefix: 400 / KY
Registered: 2020-12-23

Relationship: Self
Race: Other
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Moderna
2020-12-23
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2020-12-27
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Diarrhea

Adult check-in
2021-01-06
Survey response — day 14, dose 1
MedDRA: Arthralgia — Feeling: Good

Free text: Hip pain, mild, lasted 3 days

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-01-20
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-01-22
Dose 2 — Moderna
2021-01-24
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Lymph node pain, Swelling — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Swollen, painful lymph nodes and dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-25
Survey response — days 1–6 daily, dose 2
MedDRA: Vertigo — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Survey response — days 1–6 daily, dose 2
MedDRA: Vertigo — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Survey response — days 1–6 daily, dose 2
MedDRA: Hypertension, Vertigo — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Vertigo and high blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-28
Survey response — days 1–6 daily, dose 2
MedDRA: Physiotherapy, Vertigo — Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Systemic reaction (other): Vertigo and high blood w · Healthcare visit (other): Physical therapy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-29
Survey response — day 7, dose 2
MedDRA: Hypertension, Tinnitus, Vertigo — Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Vertigo, tinnitus, and high blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Survey response — day 14, dose 2
MedDRA: Dizziness, Hypertension, Office visit, Palpitations, Tachycardia, Tinnitus — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Severe dizziness, tinnitus, high blood pressure, and tachycardia with palpitations. · Healthcare visit (other): Outpatient high dose IV steroid infusion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Report sent to call center — day 14, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-12
Survey response — day 21, dose 2
MedDRA: Blood pressure abnormal, Tachycardia, Vestibular neuronitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Blood pressure and tachycardia worsened and associated with dyspnea. Diagnosed with vestibular neuritis affecting my right vestibular nerve.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-19
Survey response — day 28, dose 2
MedDRA: Dizziness, Dyspnoea, Vestibular neuronitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Still with dizziness related to vestibular neuritis. Still with occasional dyspnea.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-19
Report sent to call center — day 28, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-26
Survey response — day 35, dose 2
MedDRA: Dyspnoea exertional, Impaired work ability, Vestibular neuronitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Still with vestibular neuritis, dyspnea with exertion, and inability to work

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-26
Report sent to call center — day 35, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-05
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-04-23
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-04-26
Call 1 — Left Voicemail
2021-04-26
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-07-23
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-01-22
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Moderna
2	2021-01-22	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2020-12-27	priority 2/3
2021-01-27	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-28	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-05	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-12	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-19	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-26	Successful 2021-04-26	Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Hip pain, mild, lasted 3 days

Release 2 — days 1–6 daily, dose 2

2021-01-24

Systemic reaction (other): Swollen, painful lymph nodes and dizziness

2021-01-25

Systemic reaction (other): Vertigo

2021-01-26

Systemic reaction (other): Vertigo

2021-01-27

Systemic reaction (other): Vertigo and high blood pressure

2021-01-28

Systemic reaction (other): Vertigo and high blood w

Healthcare visit (other): Physical therapy

Release 3 — day 7, dose 2

2021-01-29

Systemic reaction (other): Vertigo, tinnitus, and high blood pressure

Release 3 — day 14, dose 2

2021-02-05

Symptoms: Severe dizziness, tinnitus, high blood pressure, and tachycardia with palpitations.

Healthcare visit (other): Outpatient high dose IV steroid infusion

Release 4 — day 21, dose 2

2021-02-12

Symptoms: Blood pressure and tachycardia worsened and associated with dyspnea. Diagnosed with vestibular neuritis affecting my right vestibular nerve.

Release 4 — day 28, dose 2

2021-02-19

Symptoms: Still with dizziness related to vestibular neuritis. Still with occasional dyspnea.

Release 4 — day 35, dose 2

2021-02-26

Symptoms: Still with vestibular neuritis, dyspnea with exertion, and inability to work

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
HCVO	Physiotherapy	✓	✓	✓
SD	Arthralgia	✓	✓	✓
SD	Blood pressure abnormal	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Dyspnoea exertional	✓	✓	✓
SD	Hypertension	✓	✓	✓
SD	Impaired work ability	✓	✓	✓
SD	Palpitations	✓	✓	✓
SD	Tachycardia	✓	✓	✓
SD	Tinnitus	✓	✓	✓
SD	Vestibular neuronitis	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Hypertension	✓	✓	✓
SRO	Lymph node pain	✓	✓	✓
SRO	Swelling	✓	✓	✓
SRO	Tinnitus	✓	✓	✓
SRO	Vertigo	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release